TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

637 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Parkinson's disease

    Exercise Neuroprotection in Parkinson's Disease

    Testing whether exercise changes inflammation in people with Parkinson’s

    📍 Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV · Las Vegas, NV · Get directions →

    The purpose of this study is to explore the relationships of exercise on inflammation in the body of older adults and people with Parkinson's disease (PD). This is important research for older adults but is especially important for people with PD because neuroinflammation is the main pathological mechanism that is responsible for neuron cell death in this neurodegenerative disease.

    ✓ Study care freeAges 30–85Learn more →
  • Eczema / atopic dermatitis

    Molecular Signatures of Cutaneous Dupilumab Response

    Studying how dupilumab affects immune cells in eczema skin

    📍 University of California, San Francisco · San Francisco, CA · Get directions →

    This study examines the effect of IL4RA blockade with dupilumab on the immune cells of atopic dermatitis skin lesions.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • COPD (chronic lung disease)

    A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

    Testing two doses of a medicine versus placebo for COPD symptoms

    📍 Research Site · Birmingham, AL · +39 more US sites · Get directions →

    This Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe chronic obstructive pulmonary disease.

    ✓ Study care freePhase 2Ages 40+Learn more →
  • Sickle cell disease

    Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait

    Comparing bone loss, physical function, and frailty in older women with sickle cell trait

    📍 UConn Health · Farmington, CT · Get directions →

    This is a cross-sectional, clinical research study comparing postmenopausal women of African Descent (AD) with different hemoglobin genotypes: normal and sickle cell trait (SCT). This research study has two purposes.

    ✓ Study care freeAges 50+WomenLearn more →
  • Parkinson's disease

    Exercise to Improve Sleep in Parkinson's Disease

    Testing whether different types of exercise improve sleep in Parkinson’s

    📍 Jewish Rehabilitation Hospital · Laval, Quebec · Get directions →

    This study will investigate the impact of three common exercise modalities, cardiovascular, resistance, and multimodal (i.e., a combination of the previous two) training, on sleep quality and architecture in persons with Parkinson's disease (PD). Furthermore, the project will investigate whether the potential positive exercise-induced changes in sleep are associated with improvements in different quality of life (QoL)-related aspects.

    ✓ Study care freeAges 40+Learn more →
  • Eczema / atopic dermatitis

    A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

    Studying the safety of abrocitinib use during pregnancy in eczema

    📍 Pfizer · New York, NY · Get directions →

    The purpose of this observational study is to learn about the safety of abrocitinib (CIBINQO) in pregnant women and the offspring. The study is seeking participants who: * Are currently or recently pregnant * Receive at least one dose of CIBINQO at any time during pregnancy or prior to pregnancy OR have a diagnosis of moderate-to-severe atopic dermatitis All participants in this study will receive treatment according to routine care, as this is an observational study.

    ✓ Study care freeWomenLearn more →
  • Parkinson's disease

    Parkinson's Foundation PD GENEration Genetic Registry

    Building a central database of genetic data for people with Parkinson’s to support future research

    📍 University of Alabama Birmingham · Birmingham, AL · +39 more US sites · Get directions →

    Development of a central repository for PD-related genomic data for future research.

    ✓ Study care freeAges 18+Learn more →
  • COPD (chronic lung disease)

    Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models

    Testing if wearable devices and AI can predict COPD flare-ups

    📍 McGill University Health Centre · Montreal, Quebec · Get directions →

    This study is aimed to collect real-time physiological data using two wearable devices (a biometric ring and a biometric wristband), daily lung mechanical measurements by a handheld oscillometer, and participant-reported symptoms in patients with COPD remotely from their home environment. The data will be used to train and validate artificial intelligence and machine learning (AI/ML) models to predict COPD exacerbations in advance of their actual occurrence.

    ✓ Study care freeAges 40+Learn more →
  • Parkinson's disease

    Daily Amino Acid Supplementation for People With Parkinson's Disease

    Testing whether a daily amino acid supplement improves nutrition in adults with Parkinson’s disease

    📍 University of Connecticut · Storrs, CT · Get directions →

    The goal of this clinical trial is to learn if a tailored amino acid supplement works to help adults living with Parkinson's disease to improve nutrition, metabolic function, body composition, and physical and mental function. The main questions it aims to answer are: Does the tailored amino acid supplement increase essential amino acids (nutritional status)?

    ✓ Study care freeAges 50–80Learn more →
  • COPD (chronic lung disease)

    Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

    Testing how a genetic change in alpha-1 antitrypsin affects immune and lung responses to a pneumonia

    📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →

    The goal of this study is to learn whether patients who have a genetic mutation in the genes that cause alpha 1 antitrypsin deficiency also have genetic variation in nearby genes that can increase risk for reduced immune function and respiratory infections. To investigate this hypothesis, we will compare immune responses to the 20-valent pneumococcal conjugate vaccine (PCV20, Pfizer) between participants who have one abnormal copy of the SERPINA1 gene and either no COPD exacerbations, vs those with 2 or more COPD exacerbations in the past year.

    ✓ Study care freePhase 4Ages 19+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

    Testing a remote mindful program to increase daily steps in people with COPD and heart failure

    📍 VA Boston · Boston, MA · +1 more US site · Get directions →

    The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF.

    ✓ Study care freeAges 40+Learn more →
  • Sickle cell disease

    Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

    Tracking people with sickle cell trait to understand health patterns and complications

    📍 University of Alabama · Birmingham, AL · +9 more US sites · Get directions →

    The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.

    ✓ Study care freeAges 18+Learn more →
  • Parkinson's disease

    TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

    Testing rehabilitation programs to reduce freezing of walking in Parkinson’s

    📍 Arizona State University · Tempe, AZ · +1 more US site · Get directions →

    The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention can reduce FOG and improve daily life mobility in people with FOG sufficiently to justify a clinical trial. Participants will: * Be randomly assigned to one of two intervention groups (turning-focused agility exercise or strength-based exercise) * Have one-on-one training sessions three times per week for 6 weeks * Perform in-lab assessments before beginning and after completing the study intervention * Use wearable mobility sensors during daily life to measure their walking and balance

    ✓ Study care freeAges 50–80Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

    Testing whether a tributyrin supplement helps memory, thinking, and balance in adults with Parkinson

    📍 Domino's Farms · Ann Arbor, MI · Get directions →

    The goal of this clinical trial is to learn if taking a tributyrin supplement works to improve memory and thinking and walking and balance in adults with Parkinson disease Parkinson disease dementia. It will also learn about the safety of tributyrin supplementation.

    ✓ Study care freePhase 1Ages 45+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Passive Heat Therapy for People With COPD

    Testing whether a 45-minute hot-water footbath improves blood flow in people with COPD

    📍 University of British Columbia · Kelowna, British Columbia · Get directions →

    People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath.

    ✓ Study care freeAges 40+Learn more →
  • Parkinson's disease

    Effects of RAS on Gait in PD Patients With DBS

    Testing how rhythm cues affect walking in people with Parkinson’s on and off DBS

    📍 Johns Hopkins School of Medicine · Baltimore, MD · Get directions →

    Participants will be asked to walk along with the metronome beats (RAS) during the participants' stimulation state (ON or OFF) for four minutes for each state. The researcher will collect the gait parameters (cadence, velocity, and stride length) of patients before, during, and after RAS in both DBS ON and OFF states.

    ✓ Study care freeAges 18–89Learn more →
  • Parkinson's disease

    Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

    Testing a non-invasive brain stimulation device to improve Parkinson’s movement problems

    📍 U LLC Headquarters · Cleveland, OH · Get directions →

    This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head.

    ✓ Study care freePhase 1Ages 18–80Learn more →
  • Parkinson's disease

    Sleep-specific DBS Therapy in Parkinson's Disease

    Testing how deep brain stimulation affects sleep problems in Parkinson's

    📍 University Of Minnesota · Minneapolis, MN · Get directions →

    Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and the effects of therapeutic interventions such as deep brain stimulation on sleep-related neuronal activity and sleep behavior, are not well understood.

    ✓ Study care freeAges 21+Learn more →
  • Sickle cell disease

    A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

    Testing different doses of DISC-3405 to check safety in sickle cell disease

    📍 University of Alabama at Birmingham · Birmingham, AL · +6 more US sites · Get directions →

    This is an open-label, multicenter, within-participant dose-escalation study examining up to 3 dose levels of DISC-3405 and will assess the safety, tolerability, PK, and PD of DISC 3405 in participants with sickle cell disease.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • COPD (chronic lung disease)

    📍 University of Alabama at Birmingham- Site Number : 8400003 · Birmingham, AL · +39 more US sites · Get directions →

    This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype. Participation to the study consists of 3 periods: * Screening period of up to 4 weeks * Randomized intervention period of approximately 48 weeks * Follow-up period: Approximately 8 weeks The study duration will be up to 60 weeks.

    ✓ Study care freePhase 3Ages 40–80Learn more →
  • Parkinson's disease

    Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing

    Testing how personalized touch cues and Parkinson’s medication affect walking in people with

    📍 Oregon Health and Science University · Portland, OR · Get directions →

    The purpose of the study is to determine the effects of a novel, personalized, tactile cueing system on gait automaticity. The researchers hypothesized that step-synchronized tactile cueing will reduce prefrontal cortex activity (improve automaticity) and improve gait variability (as well as gait speed).

    ✓ Study care freeAges 45–85Learn more →
  • Parkinson's disease

    Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

    Testing focused ultrasound on brain function and thinking in Parkinson's

    📍 The Regenesis Project · Santa Monica, CA · +1 more US site · Get directions →

    This is a pilot randomized, sham-controlled, double-blind, multi-center study evaluating the safety and preliminary effectiveness of the Gen0Bh Transcranial Focused Ultrasound System for the treatment of motor symptoms in individuals with idiopathic Parkinson's disease.

    ✓ Study care freeAges 22–80Learn more →
  • Parkinson's disease

    Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease

    Testing step training with a metronome to improve walking in people with Parkinson disease

    📍 University of North Carolina at Chapel Hill · Chapel Hill, NC · Get directions →

    The purpose of this research study is to determine how training to step with a metronome on both a treadmill, as well as overground, will influence the way that people with Parkinson disease walk. Using metronomes is commonly used in clinics, but the investigators will be using a combination of slow and fast frequencies to alter the way that people walk.

    ✓ Study care freeAges 50–80Learn more →
  • Eczema / atopic dermatitis

    A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

    Testing whether an experimental medicine is safe and works for eczema

    📍 Northridge Clinical Trials · Northridge, CA · +3 more US sites · Get directions →

    The purpose of this study is to learn if the study medicine (PF-08049820) is safe and effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have severe itching and rashes on the skin.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Parkinson's disease

    First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

    Testing an experimental treatment for early Parkinson’s disease in adults

    📍 Montreal Neurological Institute and Hospital · Montreal, Quebec · Get directions →

    This study is researching an experimental drug called ALN-SNCA (called "study drug"). The study is focused on people with early Parkinson's disease, a disorder of the nervous system that affects movement.

    ✓ Study care freePhase 1Ages 50–80Learn more →
  • Parkinson's disease

    Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder

    Testing whether colon tissue can show a protein linked to Parkinson’s and REM sleep behavior

    📍 Digestive Disease Associates · Branford, CT · Get directions →

    The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease or REM Sleep Behavior Disorder (RBD). The main question it aims to answer is: Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkinson's disease and RBD?

    ✓ Study care freeAges 40–99Learn more →
  • Parkinson's disease

    Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

    Testing whether a low-dose seizure medicine can help Parkinson’s psychosis

    📍 Johns Hopkins · Baltimore, MD · Get directions →

    This clinical trial will test whether AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) can improve symptoms of psychosis in Parkinson's disease. Participants will be asked to complete up to 5 in-person study visits over approximately 20 weeks.

    ✓ Study care freePhase 2Ages 40–85Learn more →
  • Parkinson's disease

    Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

    Testing how different exercise programs affect movement, fitness, and quality of life in Parkinson’s

    📍 University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building · El Paso, TX · +1 more US site · Get directions →

    Parkinson's disease (PD) is a progressive neurological condition that can affect movement, balance, endurance, and overall quality of life. Exercise is widely recognized as one of the most effective non-pharmacological treatments to help people with PD maintain function and independence.

    ✓ Study care freeAges 50+Learn more →
  • Parkinson's disease

    A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    Testing a treatment in people with early Parkinson’s disease who have an LRRK2 gene test result

    📍 Banner Sun Health Research Institute · Sun City, AZ · +39 more US sites · Get directions →

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic profile. A DNA test will be used to identify the "LRRK2-driven" population with predicted elevation in the LRRK2 pathway.

    ✓ Study care freePhase 2Ages 40–80Learn more →
  • COPD (chronic lung disease)

    A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

    Testing the long-term safety of astegolimab in people with COPD

    📍 UAB Lung Health Center · Birmingham, AL · +39 more US sites · Get directions →

    The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.

    ✓ Study care freePhase 3Ages 40–90Learn more →
  • Parkinson's disease

    Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients

    Testing osteopathic treatment to see how it affects leg muscles in Parkinson’s

    📍 NYIT College of Osteopathic Medicine · Old Westbury, NY · Get directions →

    The purpose of the study is to investigate the effects that Osteopathic Manipulative Medicine has on lower extremity muscle characteristics in PD. Muscle stiffness, range of motion, and gait will be measured.

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)

    Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

    Testing whether adding two lupus medicines to standard care improves kidney results

    📍 AARA Clinical Research · Glendale, AZ · +6 more US sites · Get directions →

    This is a Phase IV, open-label, randomized trial to determine whether the combination of Belimumab (BEL) and Voclosporin (VCS), plus background therapy with Mycophenolate Mofetil (MMF), improves the proportion of patients with proliferative lupus nephritis achieving complete renal response (CRR) compared to proportion of patients achieving CRR from recent clinical trials. This protocol will additionally determine whether combination therapy using Belimumab (BEL) and Voclosporin (VCS) facilitates rapid discontinuation of MMF.

    ✓ Study care freePhase 4Ages 18–80Learn more →
  • Parkinson's disease

    📍 University of Kentucky · Lexington, KY · Get directions →

    The investigators propose a Phase I single surgical-center, double-blinded randomized parallel clinical trial involving bilateral autologous peripheral nerve tissue (PNT) delivery into the NBM or the alternate target also affecting cognition in this population, the substantia nigra (SN), to address "repair cell" support of these areas. Twenty-four participants with idiopathic Parkinson's Disease (PD) who have selected, qualified and agreed to receive as standard of care deep brain stimulation (DBS) will be enrolled and randomly allocated to receive bilateral PNT deployment to either the NBM or SN at the time of DBS surgery.

    ✓ Study care freePhase 1Ages 45–75Learn more →
  • High blood pressureCOPD (chronic lung disease)

    Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease

    Studying how the right side of the heart works at rest and during exercise in people with COPD

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · Get directions →

    This study plans to learn about heart function among individuals with chronic obstructive pulmonary disease (COPD). In particular, the investigators want to understand the different patterns of right ventricular response during rest and moderate- vs high-intensity exercise.

    ✓ Study care freeAges 40+Learn more →
  • Parkinson's disease

    Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

    Comparing lower versus higher amounts of light exercise for Parkinson’s

    📍 Atlanta VA Medical and Rehab Center, Decatur, GA · Decatur, GA · Get directions →

    Veterans with mid to later stage Parkinson's disease (PD) may not be able to work out as hard as they need to, to prevent brain cell loss. Maybe they could work out longer and more frequently to make up for this during their good times and good weeks and then rest during the bad weeks.

    ✓ Study care freeAges 40+Learn more →
  • Parkinson's disease

    Apathy in Parkinson Disease TMS Study

    Testing non-invasive brain stimulation targets for apathy in Parkinson disease

    📍 UNC-Chapel Hill, Cassidy Lab · Chapel Hill, NC · Get directions →

    The goal of this clinical trial is to develop non-invasive brain stimulation targets for the treatment of apathy, or motivation problems, in Parkinson Disease. The main questions the study aims to answer are: 1.

    ✓ Study care freeAges 55–80Learn more →
  • Parkinson's disease

    Exercise & Brain Energetics in PD

    Testing whether exercise changes brain energy use in Parkinson’s disease

    📍 Pacific Parkinson's Research Centre · Vancouver, British Columbia · Get directions →

    There is increasing evidence that the usage and delivery of energy to the brain, known as brain energetics, is altered in people with Parkinson's disease (PD). This project will explore whether exercise has a positive impact on brain energetics using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) brain scanning in PD subjects.

    ✓ Study care freeAges 40–80Learn more →
  • Parkinson's disease

    Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

    Studying how a deep brain movement pathway works in people with Parkinson’s

    📍 University of Minnesota · Minneapolis, MN · Get directions →

    When a patient gets DBS surgery, the neurosurgeon makes a hole in the skull through which they can put the DBS lead down in deep parts of the brain that help control movement. For this study, research participants will also have an ECoG strip put through the same hole (no extra holes are being made for research purposes).

    ✓ Study care freeAges 21–75Learn more →
  • Sickle cell disease

    Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

    Testing higher doses of VAS-101 in people with stable sickle cell disease

    💵 May compensate

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: Sickle cell disease (SCD) is an inherited blood disorder. The disease affects the ability of red blood cells to carry oxygen.

    ✓ Study care freePhase 1Ages 18–90Learn more →
  • COPD (chronic lung disease)

    A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

    Testing whether tezepelumab is safe and works for adults with COPD

    📍 Research Site · Foley, AL · +39 more US sites · Get directions →

    A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    ✓ Study care freePhase 3Ages 40–80Learn more →
  • Lupus (SLE)

    📍 Investigative Site · Beverly Hills, CA · +9 more US sites · Get directions →

    The goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus erythematosus (SLE). Another goal is to learn about the safety of VENT-03 and how it is processed by the body.

    ✓ Study care freePhase 2Ages 18–80Learn more →
  • Lupus (SLE)Eczema / atopic dermatitis

    Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

    Testing whether baricitinib is safe in people with Job syndrome and lupus or eczema

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: Autosomal dominant hyper-IgE syndrome (HIES), also called Job syndrome, is a genetic disorder that affects the immune system. It can cause skin and lung infections and problems with blood vessels, connective tissues, and bones.

    ✓ Study care freePhase 1Ages 12–120Learn more →
  • Parkinson's disease

    SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease

    Testing a Segway-based training program to improve balance and thinking in people with Parkinson’s

    📍 University of Texas Southwestern Medical Center · Dallas, TX · Get directions →

    The purpose of this study is to examine the safety and efficacy of postural training emphasized on the integration of multiple sensory information into motor control in individuals with PD. This project is a proof-of-concept study to assess the effectiveness of postural training using Segway, which serves a platform to provide augmented and continuous proprioceptive and visuospatial information during postural training.

    ✓ Study care freeAges 50–85Learn more →
  • Parkinson's disease

    A Study of Buntanetap in Participants With PD

    Testing the long-term safety of buntanetap in people with Parkinson’s

    📍 University of Alabama at Birmingham · Birmingham, AL · +26 more US sites · Get directions →

    This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study.

    ✓ Study care freePhase 2Ages 40–85Learn more →
  • Eczema / atopic dermatitis

    Metabolic Profiling of Immune Responses in Immune-mediated Diseases

    Studying immune system responses in people with eczema

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: The immune system is the part of the body that fights infection. Some people have immune deficiencies that cause skin rashes, make them get sick often with infections, or make it difficult for their skin to heal.

    ✓ Study care freeAges 18–75Learn more →
  • Eczema / atopic dermatitis

    Cardamom and Topical Roseomonas in Atopic Dermatitis

    Testing cardamom and a skin-applied germ to treat eczema

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: Atopic dermatitis (AD), also called eczema, is a chronic skin condition. AD can make skin dry and itchy, and sometimes it can lead to serious health problems, such as asthma, food allergies, eye infections, and sleep problems.

    ✓ Study care freePhase 2Ages 2–100Learn more →
  • COPD (chronic lung disease)

    Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

    Analyzing how a COPD inhaler is used in routine care settings

    📍 Research Site · Mississauga, · Get directions →

    The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.

    ✓ Study care freeAges 18+Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    PET Imaging Evaluation of [11C]SY08

    Testing a PET scan tracer to detect alpha-synuclein protein clumps in dementia and Parkinson’s

    📍 MGH · Charlestown, MA · Get directions →

    The overall goal of the proposed research is to evaluate the use of \[11C\]SY08 as a PET radiotracer for aggregated alpha synuclein (αS) in individuals with Parkinson's disease (PD), Multiple system atrophy (MSA), Dementia with Lewy Bodies (DLB) and healthy controls. The purpose of this study is to evaluate the use of \[11C\]SY08 as a PET radiotracer for αS fibrils in individuals with PD, MSA, DLB and healthy controls.

    ✓ Study care freeEarly Phase 1Ages 50–80Learn more →
  • Eczema / atopic dermatitis

    Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

    Collecting skin samples from people with eczema and healthy volunteers

    📍 Innovaderm Research Inc. · Montreal, Quebec · Get directions →

    The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)

    CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

    Testing a cell therapy made from a person’s own immune cells for lupus

    📍 Children's Hospital of Philadelphia · Philadelphia, PA · Get directions →

    This is a single-center, single-arm, open-label phase 1/2 study of CART19 in children and young adults with refractory Systemic lupus erythematosus (SLE), including both patients diagnosed with lupus nephritis (LN) and patients with non-renal Systemic lupus erythematosus (SLE). Phase 1 will evaluate the safety of CART19 in 6-12 patients with Systemic lupus erythematosus (SLE).

    ✓ Study care freePhase 1Ages 12–29Learn more →
  • Eczema / atopic dermatitis

    Registry for Systemic Eczema Treatments

    Collecting health data from children with eczema who use systemic treatments

    📍 Johns Hopkins University · Baltimore, MD · Get directions →

    The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.

    ✓ Study care freeAges 1–26Learn more →
  • Sickle cell disease

    Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease

    Testing a stress-management and mindfulness program to improve quality of life in people with sickle

    📍 University of Pennsylvania · Philadelphia, PA · Get directions →

    The purpose of this research is to determine whether a new stress management and mindfulness program can improve quality of life in individuals with sickle cell disease. The program is based on a number of empirically supported treatments including techniques from cognitive-behavioral therapy like overcoming motivational barriers to self-care, learning to see things as accurately as possible, practicing assertive communication, relaxation exercises like deep slow breathing, mindfulness meditation, and other stress management strategies.

    ✓ Study care freeAges 18+Learn more →
  • Lupus (SLE)

    US Zamto-cel Autoimmune Diseases

    Testing the safety of an experimental cell therapy for lupus

    📍 Froedtert Hospital and the Medical College of Wisconsin · Milwaukee, WI · Get directions →

    AID is a phase I multi-cohort study to assess the safety and tolerability of zamtocabtagene autoleucel (zamto-cel) in patients with refractory autoimmune diseases (SLE-Non renal, SLE-LN, SSc/dcSSc) after receiving standard therapy.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Lupus (SLE)

    Dapagliflozin in Active Lupus Nephritis

    Testing dapagliflozin for lupus-related kidney inflammation (kidney disease)

    📍 Massachusetts General Hospital · Boston, MA · +1 more US site · Get directions →

    Lupus nephritis is a chronic and life-threatening autoimmune cause of kidney disease that predominately impacts young people and can lead to kidney failure. Sodium-glucose co-transporter-2 inhibitors, including dapagliflozin, are known to improve outcomes for people with other causes of chronic kidney disease.

    ✓ Study care freePhase 4Ages 18–70Learn more →
  • Sickle cell disease

    SMYLS Multi-site Trial

    Testing a mobile app and website to help teens manage sickle cell symptoms

    📍 Medical University of South Carolina · Charleston, SC · Get directions →

    The purpose of this study is to find out whether a web-based intervention using a mobile app is helpful for teens and young adults with sickle cell disease (SCD) in learning how to care for and manage their symptoms.

    ✓ Study care freeAges 14–21Learn more →
  • Parkinson's disease

    A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

    Studying how Parkinson's disease changes over time in people with ongoing movement symptoms despite

    📍 Banner Alzheimer's Institute (BAI)-Phoenix · Phoenix, AZ · +25 more US sites · Get directions →

    This is an observational study in which data are collected and studied from Parkinson's disease patients who have movement symptoms despite taking standard Parkinson's medications. In observational studies, observations are made without any changes to the participant's healthcare or treatment plan.

    ✓ Study care freeAges 45–75Learn more →
  • Sickle cell disease

    A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

    Testing the safety and how an oral carbon monoxide liquid works in sickle cell disease

    📍 Cevaxin - The Panama Clinic · Panama City, · Get directions →

    This is a multi-center, open label Phase 2a clinical trial in subjects with sickle cell disease to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of HBI-002, an orally administered liquid containing carbon monoxide (CO), with doses daily for 14 days.

    ✓ Study care freePhase 1Ages 18–55Learn more →
  • Sickle cell disease

    Sickle Cell Improvement: Enhancing Care in the Emergency Department

    Improving emergency care for people with sickle cell disease pain

    📍 Children's Wisconsin · Milwaukee, WI · Get directions →

    Sickle cell disease (SCD) is an inherited blood disorder affecting approximately 36,000 children in the United States, approximately 90% of whom are Black. The disease is characterized by recurrent, severe pain crises which result in high rates of emergency department visits and hospitalizations, and decreased quality of life.

    ✓ Study care freeLearn more →
  • Dementia / Alzheimer'sParkinson's disease

    Impact of a Biophoton Therapy on Patients With Brain Disorders

    Testing a light-based therapy for people with dementia or Parkinson’s

    📍 Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001 · Butler, PA · Get directions →

    Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research.

    ✓ Study care freeAges 18+Learn more →
  • Sickle cell disease

    Integrative Medicine in Pain Management in Sickle Cell Disease, 2.0

    Testing whether acupuncture can reduce pain in people with sickle cell disease

    💵 May compensate

    📍 Indiana University School of Medicine · Indianapolis, IN · Get directions →

    The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.

    ✓ Study care freeAges 14–80Learn more →
  • Showing the first 60 of 637. Add filters or a location to narrow down.